Nephros, Inc.
NEPH
$4.36
$0.307.39%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 24.20% | 23.25% | 32.67% | 32.36% | 21.16% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 24.20% | 23.25% | 32.67% | 32.36% | 21.16% |
| Cost of Revenue | 31.35% | 31.46% | 31.72% | 24.90% | 12.01% |
| Gross Profit | 20.07% | 18.31% | 33.27% | 37.13% | 27.17% |
| SG&A Expenses | 17.84% | 18.99% | 17.25% | 4.15% | -6.75% |
| Depreciation & Amortization | -12.68% | -7.80% | 3.70% | -6.58% | -17.92% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.32% | 25.11% | 24.63% | 13.64% | 1.37% |
| Operating Income | 22.81% | -12.31% | 19,000.00% | 250.52% | 197.66% |
| Income Before Tax | 29.68% | -3.43% | 1,255.06% | 262.33% | 204.40% |
| Income Tax Expenses | -33.33% | -20.00% | -20.00% | -- | -- |
| Earnings from Continuing Operations | 30.82% | -3.12% | 1,513.51% | 259.42% | 202.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 30.82% | -3.12% | 1,513.51% | 259.42% | 202.55% |
| EBIT | 22.81% | -12.31% | 19,000.00% | 250.52% | 197.66% |
| EBITDA | 19.26% | -12.02% | 800.00% | 296.90% | 224.06% |
| EPS Basic | 28.29% | -3.31% | 1,531.88% | 257.90% | 201.70% |
| Normalized Basic EPS | 27.19% | -3.74% | 1,292.16% | 260.36% | 203.37% |
| EPS Diluted | 29.29% | -6.67% | 21,060.00% | 240.11% | 191.01% |
| Normalized Diluted EPS | 24.28% | -6.65% | 1,268.63% | 258.38% | 202.98% |
| Average Basic Shares Outstanding | 1.13% | 0.75% | 0.86% | 0.76% | 0.79% |
| Average Diluted Shares Outstanding | 4.19% | 4.23% | 3.62% | 2.25% | 1.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |